Sterility Testing Market Research Report - Global Forecast till 2027

Sterility Testing Market Research Report:  Product Type (Instruments, Services), Test Type (Membrane Filtration, Direct Transfer) End-User (Pharmaceutical Companies, Hospitals & Clinics, Academic & Research Laboratories) – Global Forecast Till 2027

ID: MRFR/LS/0104-CR | June 2018 | Region: Global | 115 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


It is expected that the global sterility testing market will grow at a CAGR of 11.7% during the forecast period (2017-2023). It is projected that the market will expand up to USD 1245.2 million by the year 2023. The increasing pervasiveness of cancer-related and cardiovascular diseases are considered to fuel the demand for sterility tests across the world.


Pharmaceuticals Sterility testing is mainly used any for research and development and check the quality of manufactured drugs. It is an important step that is used to know whether the drugs are safe for consumption. Sterility testing is beneficial for patients suffering from cardiovascular or cancer diseases. It is also used for cell banks, raw materials and the final product of drugs.


COVID-19 Analysis


The outbreak of COVID-19 disease had largely affected the global sterility testing market. Due to the COVID-19, industries in various sectors were forced to shut down their offices and productions temporarily for several months. The lockdown had severely affected the production of such drugs and hindered the scientists' and experts' research work.  However, companies have resumed the production, but it will take a few years to get back to their previous pace.


Market Dynamics


Drivers


Pharmaceutical sterility testing is conducted to investigate any impurity and confirm the safety of the pharmaceutical drugs. Increasing cases of patients suffering from cardiovascular diseases such as heart failure, heart attack, high blood pressure, etc., and cancer-related diseases are expected to boost the market. Also, support by the government for research and investments and rising healthcare centers and research institutes are the major market drivers of sterility testing.


Restraints


Sterility testing is an essential step for determining the quality of pharmaceutical drugs. But, stringent rules and regulations by the government authorities in many countries can hamper the growth of the sterility testing market to a certain extent.


Opportunities


According to reports, the FDA Centre for Drug Evaluation and Research has approved 59 drugs under new drugs in the year 2018. This means the number of drugs is gradually increasing every year. This is a great opportunity for the sterility testing industry to bloom.


Challenges


The strict framework for regulation by the authorities will be a major challenge for the pharmaceutical companies to conduct sterility testing. The long and exhausting process for approval and fewer trained professionals are some challenges for the global market of sterility testing.


Cumulative Growth Analysis


The pharmaceutical sterility testing market is projected to have a comprehensive growth rate (CAGR) of 11.7% by the year 2023. It is projected that the market will expand more in the forthcoming years and will reach around USD 1245.2 million by the year 2023. The increasing numbers of patients who have cancer and cardiovascular diseases and technological advancements by the pharmaceutical industries are the factors expected to propel the global market.


Value Chain Analysis


The healthcare treatment for cancer and cardiovascular diseases is very expensive. Due to this reason, the use of sterility testing is expected to gain more importance. It is expected that in a few years, sterility testing market size will expand, and it will be helpful to determine the quality of the pharmaceutical drugs. Market development primarily depends upon technological development and its usage during the process.


Segment Overview


The global sterility testing market is segmented into test type, product type, services and end-user. The segment of services is further divided into sterility validations, stability testing, assurance tests for sterility, and disinfection and cleaning. These tests are conducted t know the sterility assurance level (SAL) of the pharmaceutical products.


Based on product type, the global sterility market is divided into- consumables, instruments and services.


According to test type, sterility testing market is bifurcated into membrane filtration sterility testing, product flush sterility testing, direct transfer sterility testing, etc.


Based upon End-user, sterility testing market is segmented into pharmaceutical companies, research and academic laboratories, clinics and hospitals, etc. The increasing treatments of chronic diseases like cardiovascular diseases, cancer, etc., have increased the demand for sterility testing.


Regional Analysis


Geographically, the Global Sterility Testing Market is segmented into four regions-the Americas, Asia-Pacific (APAC), Europe and the Middle East and Africa.


The U.S. pharmaceutical sterility testing market expected to hold the largest share in the global market of Sterility Testing. Increasing technological advancements in the pharmaceutical industries and heavy expenditure on research and developments are the major drivers of the market.


The Asia-Pacific region is anticipated to have the fastest growth in the global sterility testing industry during the forecast period. Technological advancements, rising awareness for healthcare, increasing healthcare facilities are the main reasons for the rapid development. Also, increasing investments and expenditure on research and developments played a major role in developing the economy.


Countries in the European region hold the largest market share in the sterility testing industry after the Americas. The increasing key players in the pharmaceutical industries and investments in the research and developments and availability of the best healthcare facilities are the reasons for the market boost.


In the Middle East and African region, the sterility testing market is considered to have a slow and steady growth. Lacks of health awareness, equipment, and less specialized consultants are the major reasons for the lack of growth.


Competitive Landscape



  1. Several companies use business strategies such as mergers, acquisitions, collaborations, etc., to expand their business. Merck KGaA is one of the key market players in the competitive landscape of the global sterility testing products. It has also acquired Sigma-Aldrich Corporation worth USD 17 billion. The acquisition was helpful to expand the business and strengthen its position in the global market.


Here is the list of some competitive companies in the sterility testing market-



  • BioMérieux SA (France)

  • Thermo Fisher Scientific, Inc. (U.S.)

  • Merck KGaA (Germany)

  • Sartorius AG (Germany)

  • Charles River Laboratories International, Inc. (U.S.)

  • WuXi AppTec (China)

  • Astell Scientific (U.K.)

  • Becton, Dickinson and Company (U.S.)

  • SA, Pacific BioLabs Inc. (U.S.)

  • Belimed Deutschland GmbH (Massachusetts)

  • Bioquell U.K. Ltd (U.K.)


Recent Developments



  1. In the year 2015, Danaher announced its acquisition of Pall Corporation. The acquisition was aimed to include sterility filtration products of Pall Corporation to expand its business portfolio.

  2. In the year 2014, Merck KGaA launched a new product called Steritest Symbio pumps. The product was aimed to help the researchers for safer, reliable, faster and sterility testing in any condition.

  3. Nelson Laboratories in 2014 announced its expansion with the technical Consulting Services group. The expansion was aimed to provide services for process validation, regulatory support, product development and performance testing.


Report Overview


The global Sterility Testing market gives various information and insights about the forecast.  The overview of the report is the same as follows-



  • Overview of the global market of Sterility Testing Industry

  • COVID-19 Analysis

  • Market Dynamics

  • Value Chain Analysis

  • Segmentation of the market

  • Regional Analysis

  • Competitive landscape

  • Recent developments made by the key players of the market.


Report Score and Segmentation


The score of the report gives insight and clarity about the global sterility testing market. It gives the information and highlights the market’s strength. Furthermore, the report also provides information regarding the contribution of key players that affect the market growth.


By Test Type


  • Direct Transfer Sterility Testing

  • Membrane Filtration Sterility Testing

  • Product Flush Sterility Testing

  • Others


By Product


  • Services



  1. Sterilization validations

  2. Stability testing

  3. Sterility assurance tests

  4. Disinfection and cleaning

  5. others



  • Consumables

  • Instruments


By End-User


  • Clinics and Hospitals

  • Research and Academic Institutes

  • Pharmaceutical Companies

  • Others


By Region


  • North America

  • Latin America

  • Asia

  • Europe

  • Middle East & Africa



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 1245.2 Million
  • 2027: Significant Value
  •   CAGR   11.7% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product Type, Test Type, End-User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   BioMérieux SA (France), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Charles River Laboratories International, Inc. (U.S.), WuXi AppTec (China), Astell Scientific (U.K.), Becton, Dickinson and Company (U.S.), SA, Pacific BioLabs Inc. (U.S.),Belimed Deutschland GmbH (Massachusetts), Bioquell U.K. Ltd (U.K.)
      Key Market Opportunities   FDA Centre for Drug Evaluation and Research has approved drugs
      Key Market Drivers

  • Increasing cases of patients suffering from cardiovascular diseases
  • Support by the government for research and investments
  • Rising healthcare centers and research institutes


  • Frequently Asked Questions (FAQ) :


    The Global Sterility Testing Market size can reach USD 1,245.2 million by 2023.

    The Global Sterility Testing Market is expected to fetch high returns at a CAGR of 11.7% from 2020 to 2027.

    High prevalence of chronic diseases and testing of brand new drugs are major drivers of the Global Sterility Testing Market.

    Pharmaceutical companies are the end-users which can contribute the most to the Global Sterility Testing Market.

    The Americas held the largest share in the global sterility testing market owing to advances in pharmaceutical formulations and presence of various top-end manufacturers.

    The APAC region can display a CAGR of 12.4% from 2020 to 2027 in the Global Sterility Testing Market.

    Merck KGaA, SGS SA, Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Astell Scientific, Pacific BioLabs Inc., Boston Scientific Corporation, bioMérieux SA, Baxter BioPharma Solutions, WuXi AppTec, Becton, Dickinson and Company, Belimed Deutschland GmbH, Bioquell U.K. Ltd., and Sartorius AG are the key players in the global sterility testing market.

    Global Sterility Testing Market: Report Summary


    The global sterility testing market is predicted to touch USD 1,245.2 million by 2023 from USD 575 million in 2016, expanding at an astounding CAGR of 11.7% during the assessment period (2017-2023). The rise in demands for sterile drugs can open up avenues for suppliers and manufacturers of sterility testing market. Developing countries, such as China and India, owing to advancements in biotechnology and pharmaceuticals, are emerging as prospective markets and have turned out to be the favorite destination of investment of various market players who are now expanding their operations in these regions.


    The sterility testing market is segmented on the basis of product type, test type, and end-user. By product type, the global market for sterility testing is segmented into instruments, consumables, and services. The service segment is sub-segmented into sterility assurance tests, sterilization validations, cleaning and disinfection, stability testing, and others. Mostly, sterility assurance tests are performed to determine the sterility-assurance level (SAL) of perishable pharmaceutical products, such as injectable to ensure the sterility of the drugs. Owing to these features, the sterility assurance tests segment held the largest market in 2016 with a market valuation of USD 67.1 million. Current predictions estimate its valuation at USD 151.6 million by the end of the forecast period.


    Segmentation based on test type includes membrane filtration sterility testing, direct transfer sterility testing, product flush sterility testing, and others. The membrane filtration sterility test is a regulatory method for filterable pharmaceutical samples containing preservatives, bacteriostatic compounds, inhibiting the microbial growth of potential contaminants. This method helps in retaining microorganisms via 0.45-micron pore size filter, and suitable solutions are used to rinse all the inhibiting compounds. The technique is followed by the selection of an appropriate media to support the growth of anaerobic and aerobic microorganisms on the membrane filters. The final results come after an incubation period of 14 days. Furthermore, its advantages, such as applicability to large volume samples and ability to remove inhibitory substances from the sample, boost the growth of this segment. Currently, the membrane filtration sterility testing segment generates the largest market share and is expected to reach USD 348.6 million by 2023 with a stellar CAGR of 12.1% during the forecast period.


    End-users comprise pharmaceutical companies, hospital & clinics, academic & research laboratories, and others. Treatment of chronic diseases, such as cancer, cardiovascular diseases, and others have spurred the demands for sterile injectables, which in turn ensured pharmaceutical companies’ domination of the global market.  A staggering growth has been predicted for this segment where it can reach USD 428.0 million, at a CAGR of 12.1% by the end of the foreccast period.


    Regional Market Summary


    The global sterility testing market, by regions, is segmented into the Americas, Europe, Asia Pacific (APAC) and the Middle East and Africa (MEA).


    The Americas accounted for the most significant market share of about 42.1% in the global sterility testing market due to the presence of top-tier manufacturers, surging technological advancement in the pharmaceutical and biotechnology industries, and others.


    Europe accounted for the second largest market share. The market in the region is experiencing a rapid increase in healthcare expenditures, and this can act as a market booster for sterility testing market.


    The APAC market is expected to register the fastest CAGR of 12.4% during the forecast period. The region has a lot of developing economies with markets offering various opportunities making it a potential global influencer.  


    The MEA has a few deterrents, such as the presence of low-income countries and stringent government regulations, which impeded the growth in the past. The MEA market accounted for the least market share in 2016.


    Competitive Analysis


    The key players of the global sterility testing market include Merck KGaA, Charles River Laboratories Inc., BioMérieux SA, Thermo Fisher Scientific Inc., BD, SGS SA, Baxter BioPharma Solutions, and others. Between 2014 and 2017, the primary market players were trying to sustain by adopting various growth strategies, such as expansion and mergers & acquisitions. For instance, BioMérieux SA acquired the U.S. company BioFire in 2014. Recently, consolidations are being witnessed in the market with the latest being the acquisition of MPI Research by Charles River Laboratories Inc. in 2018. Due to the substantial investments made by the key market players in expanding across borders, the global sterility testing market is experiencing an extensive growth.

    1 Report Prologue

    2 Market Introduction

    2.1 Introduction 15

    2.2 Assumptions & Limitations 15

    3 Research Methodology

    3.1 Research Process 18

    3.2 Primary Research 18

    3.3 Secondary Research 18

    3.4 Market Size Estimation 19

    4 Market Dynamics

    4.1 Introduction 21

    4.2 Drivers 22

    4.2.1 Increasing Demand For Sterile Drugs For The Treatment Of Medical Conditions Such As Cancer,

    Cardiovascular Diseases, And Others 22

    4.2.2 Growing Pharmaceutical And Biotechnology Sector Provides Suitable Backgrounds For The Market Growth 22

    4.2.3 Increasing Government Funding In The Medical Sector 22

    4.2.4 Rising Investments In Life Sciences 22

    4.2.5 Drivers Impact Analysis 23

    4.3 Restraints 23

    4.3.1 High Cost Of Sterility Tests 23

    4.3.2 Prolonged Storage Of Perishable Pharmaceutical Products And Need Of Trained Professionals 23

    4.3.3 Restraints Impact Analysis 24

    4.4 Opportunity 24

    4.4.1 Untapped Markets Of The Asia Pacific Region 24

    4.5 Mega Trends 24

    4.5.1 Increasing Adoption Of Rapid Sterility Testing 24

    4.6 Macroeconomic Indicator 24

    5 Market Factor Analysis

    5.1 Value Chain Analysis 27

    5.1.1 R&D & Designing 27

    5.1.2 Manufacturing 27

    5.1.3 Distribution & Sales 27

    5.1.4 Post-Sales Review 28

    5.2 Porter’s Five Forces Model 28

    5.2.1 Bargaining Power Of Suppliers 29

    5.2.2 Bargaining Power Of Buyers 29

    5.2.3 Threat Of New Entrants 29

    5.2.4 Threat Of Substitutes 29

    5.2.5 Intensity Of Rivalry 29

    5.3 Investment Opportunities 30

    5.4 Pricing Analysis 30

    6 Sterility Testing Market, By Product Type

    6.1 Introduction 32

    6.2 Instruments 33

    6.3 Consumables 33

    6.4 Services 33

    7 Sterility Testing Market, By Test Type

    7.1 Introduction 35

    7.2 Membrane Filtration Sterility Testing 36

    7.3 Direct Transfer Sterility Testing 36

    7.4 Product Flush Sterility Testing 36

    8 Sterility Testing Market, By End User

    8.1 Introduction 38

    8.2 Pharmaceutical Companies 39

    8.3 Hospital & Clinics 39

    8.4 Academic & Research Laboratories 39

    9 Global Sterility Testing Market, By Region

    9.1 Introduction 41

    9.2 Americas 42

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.2.1 North America 44

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.2.1.1 US 46

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.2.1.2 Canada 47

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.2.2 South America 49

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3 Europe 51

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1 Western Europe 53

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.1 Germany 55

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.2 France 56

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.3 U.K 58

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.4 Italy 59

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.5 Spain 61

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.1.6 Rest Of Europe 62

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.3.2 Eastern Europe 64

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4 Asia Pacific 66

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4.1 China 68

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4.2 India 70

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4.3 Japan 71

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4.4 Australia 73

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.4.5 Rest Of Asia Pacific 74

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.5 Middle East & Africa 76

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.6 Middle East 78

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    9.6.1 Africa 79

    Sterility Testing Market, By Product Type

    Sterility Testing Market, By Test Type

    Sterility Testing Market, By End User

    10 Competitive Landscape

    10.1 Competitive Landscape 82

    10.2 Competitive Landscape 83

    10.2.1 Introduction 83

    11 Company Profiles

    11.1 Merck KGaA 85

    11.1.1 Company Overview 85

    11.1.2 Products Offering 86

    11.1.3 Key Developments 86

    11.1.4 SWOT Analysis 86

    11.1.5 Key Strategy 86

    11.2 Pacific BioLabs Inc. 87

    11.2.1 Company Overview 87

    11.2.2 Products Offering 87

    11.2.3 Key Developments 87

    11.2.4 SWOT Analysis 87

    11.3 Belimed Deutschland GmbH 88

    11.3.1 Company Overview 88

    11.3.2 Products Offering 89

    11.3.3 Key Developments 89

    11.3.4 SWOT Analysis 89

    11.3.5 Key Strategy 89

    11.4 Boston Scientific Corporation 90

    11.4.1 Company Overview 90

    11.4.2 Products Offering 91

    11.4.3 Key Developments 91

    11.4.4 SWOT Analysis 91

    11.4.5 Key Strategy 91

    11.5 Charles River Laboratories Inc. 92

    11.5.1 Company Overview 92

    11.5.2 Products Offering 93

    11.5.3 Key Developments 93

    11.5.4 SWOT Analysis 93

    11.5.5 Key Strategy 93

    11.6 Sartorius AG 94

    11.6.1 Company Overview 94

    11.6.2 Products Offering 95

    11.6.3 Key Developments 95

    11.6.4 SWOT Analysis 95

    11.6.5 Key Strategy 95

    11.7 BioMérieux SA 96

    11.7.1 Company Overview 96

    11.7.2 Products Offering 97

    11.7.3 Key Developments 97

    11.7.4 SWOT Analysis 97

    11.7.5 Key Strategy 97

    11.8 Baxter BioPharma Solutions 98

    11.8.1 Company Overview 98

    11.8.2 Products Offering 99

    11.8.3 Key Developments 99

    11.8.4 SWOT Analysis 99

    11.8.5 Key Strategy 99

    11.9 Astell Scientific 100

    11.9.1 Company Overview 100

    11.9.2 Products Offering 100

    11.9.3 SWOT Analysis 100


    11.10 SGS SA 101

    11.10.1 Company Overview 101

    11.10.2 Products Offering 102

    11.10.3 Key Developments 102

    11.10.4 SWOT Analysis 102

    11.10.5 Key Strategy 102

    11.11 Thermo Fisher Scientific Inc. 103

    11.11.1 Company Overview 103

    11.11.2 Products Offering 104

    11.11.3 Key Developments 104

    11.11.4 SWOT Analysis 104

    11.11.5 Key Strategy 104

    11.12 Becton, Dickinson And Company 105

    11.12.1 Company Overview 105

    11.12.2 Products Offering 105

    11.12.3 Key Developments 106

    11.12.4 SWOT Analysis 106

    11.12.5 Key Strategy 106

    11.13 WuXi AppTec 107

    11.13.1 Company Overview 107

    11.13.2 Products Offering 107

    11.13.3 Key Developments 107

    11.13.4 SWOT Analysis 107

    11.14 Bioquell UK Ltd 108

    11.14.1 Company Overview 108

    11.14.2 Products Offering 108

    11.14.3 SWOT Analysis 108

    11.15 Azbil Telstar S.L. 109

    11.15.1 Company Overview 109

    11.15.2 Products Offering 109

    11.15.3 SWOT Analysis 109

    12 MRFR Conclusion 110

    12.1 Key Findings 111

    12.1.1 From CEO’s View Point 111

    12.2 Key Companies To Watch 111

    13 Appendix 112

    13.1 Discussion Blue Print 113

    13.2 Recent Developments, 2020–2020 114

    12 List Of Tables

    TABLE 1 GLOBAL STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 32

    TABLE 2 GLOBAL STERILITY TESTING MARKET FOR INSTRUMENTS 2020-2027 (USD MILLION) 33

    TABLE 3 GLOBAL STERILITY TESTING MARKET FOR CONSUMABLES 2020-2027 (USD MILLION) 33

    TABLE 4 GLOBAL STERILITY TESTING MARKET FOR SERVICES 2020-2027 (USD MILLION) 33

    TABLE 5 GLOBAL STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 35

    TABLE 6 GLOBAL STERILITY TESTING MARKET FOR MEMBRANE FILTRATION STERILITY TESTING 2020-2027 (USD MILLION) 36

    TABLE 7 GLOBAL STERILITY TESTING MARKET FOR DIRECT TRANSFER STERILITY TESTING 2020-2027 (USD MILLION) 36

    TABLE 8 GLOBAL STERILITY TESTING MARKET FOR PRODUCT FLUSH STERILITY TESTING 2020-2027 (USD MILLION) 36

    TABLE 9 GLOBAL STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 38

    TABLE 10 GLOBAL STERILITY TESTING MARKET FOR PHARMACEUTICAL COMPANIES 2020-2027 (USD MILLION) 39

    TABLE 11 GLOBAL STERILITY TESTING MARKET FOR HOSPITAL & CLINICS 2020-2027 (USD MILLION) 39

    TABLE 12 GLOBAL STERILITY TESTING MARKET FOR ACADEMIC & RESEARCH LABORATORIES 2020-2027 (USD MILLION) 39

    TABLE 13 GLOBAL STERILITY TESTING MARKET BY REGION 2020-2027 (USD MILLION) 41

    TABLE 14 AMERICAS STERILITY TESTING MARKET BY REGION 2020-2027 (USD MILLION) 42

    TABLE 15 AMERICAS STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 43

    TABLE 16 AMERICAS STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 43

    TABLE 17 AMERICAS STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 44

    TABLE 18 NORTH AMERICA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 44

    TABLE 19 NORTH AMERICA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 45

    TABLE 20 NORTH AMERICA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 45

    TABLE 21 US STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 46

    TABLE 22 US STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 46

    TABLE 23 US STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 47

    TABLE 24 CANADA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 47

    TABLE 25 CANADA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 48

    TABLE 26 CANADA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 48

    TABLE 27 SOUTH AMERICA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 49

    TABLE 28 SOUTH AMERICA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 49

    TABLE 29 SOUTH AMERICA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 50

    TABLE 30 EUROPE STERILITY TESTING MARKET BY REGION 2020-2027 (USD MILLION) 51

    TABLE 31 EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 52

    TABLE 32 EUROPE STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 52

    TABLE 33 EUROPE STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 53

    TABLE 34 WESTERN EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 53

    TABLE 35 WESTERN EUROPE STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 54

    TABLE 36 WESTERN EUROPE STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 54

    TABLE 37 GERMANY STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 55

    TABLE 38 GERMANY STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 55

    TABLE 39 GERMANY STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 56

    TABLE 40 FRANCE STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 56

    TABLE 41 FRANCE STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 57

    TABLE 42 FRANCE STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 57

    TABLE 43 U.K STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 58

    TABLE 44 U.K STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 58

    TABLE 45 U.K STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 59

    TABLE 46 ITALY STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 59

    TABLE 47 ITALY STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 60

    TABLE 48 ITALY STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 60

    TABLE 49 SPAIN STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 61

    TABLE 50 SPAIN STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 61

    TABLE 51 SPAIN STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 62

    TABLE 52 REST OF EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 62

    TABLE 53 REST OF EUROPE STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 63

    TABLE 54 REST OF EUROPE STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 63

    TABLE 55 EASTERN EUROPE STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 64

    TABLE 56 EASTERN EUROPE STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 64

    TABLE 57 EASTERN EUROPE STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 65

    TABLE 58 ASIA PACIFIC STERILITY TESTING MARKET BY REGION 2020-2027 (USD MILLION) 66

    TABLE 59 ASIA PACIFIC STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 67

    TABLE 60 ASIA PACIFIC STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 67

    TABLE 61 ASIA PACIFIC STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 68

    TABLE 62 CHINA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 68

    TABLE 63 CHINA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 69

    TABLE 64 CHINA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 69

    TABLE 65 INDIA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 70

    TABLE 66 INDIA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 70

    TABLE 67 INDIA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 71

    TABLE 68 JAPAN STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 71

    TABLE 69 JAPAN STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 72

    TABLE 70 JAPAN STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 72

    TABLE 71 ASUTRALIA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 73

    TABLE 72 ASUTRALIA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 73

    TABLE 73 ASUTRALIA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 74

    TABLE 74 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 74

    TABLE 75 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 75

    TABLE 76 REST OF ASIA PACIFIC STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 75

    TABLE 77 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY REGION 2020-2027 (USD MILLION) 76

    TABLE 78 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 76

    TABLE 79 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 77

    TABLE 80 MIDDLE EAST & AFRICA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 77

    TABLE 81 MIDDLE EAST STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 78

    TABLE 82 MIDDLE EAST STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 78

    TABLE 83 MIDDLE EAST STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 79

    TABLE 84 AFRICA STERILITY TESTING MARKET BY PRODUCT TYPE 2020-2027 (USD MILLION) 79

    TABLE 85 AFRICA STERILITY TESTING MARKET BY TEST TYPE 2020-2027 (USD MILLION) 80

    TABLE 86 AFRICA STERILITY TESTING MARKET BY END USER 2020-2027 (USD MILLION) 80

    13 List Of Figures

    FIGURE 1 MARKET STRUCTURE 16

    FIGURE 2 RESEARCH PROCESS 18

    FIGURE 3 MARKET DYNAMICS ANALYSIS OF THE GLOBAL STERILITY TESTING MARKET 21

    FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL STERILITY TESTING MARKET 23

    FIGURE 5 RESTRAINTS IMPACT ANALYSIS: STERILITY TESTING MARKET 24

    FIGURE 6 VALUE CHAIN: GLOBAL STERILITY TESTING MARKET 27

    FIGURE 7 PORTER’S FIVE FORCES MODEL: GLOBAL STERILITY TESTING MARKET 28

    FIGURE 8 GLOBAL STERILITY TESTING MARKET BY PRODUCT TYPE 2020 & 2027 (USD MILLION) 32

    FIGURE 9 GLOBAL STERILITY TESTING MARKET BY TEST TYPE 2020 & 2027 (USD MILLION) 35

    FIGURE 10 GLOBAL STERILITY TESTING MARKET BY END USER 2020 & 2027 (USD MILLION) 38

    FIGURE 11 GLOBAL STERILITY TESTING MARKET BY REGION MARKET SHARE 2020 (%) 41

    FIGURE 12 AMERICAS STERILITY TESTING MARKET SHARE BY REGION 2020 (%) 42

    FIGURE 13 EUROPE STERILITY TESTING MARKET SHARE BY REGION 2020 (%) 51

    FIGURE 14 ASIA PACIFIC STERILITY TESTING MARKET SHARE BY REGION 2020 (%) 66

    FIGURE 15 MIDDLE EAST & AFRICA STERILITY TESTING MARKET SHARE BY REGION 2020 (%) 76

    FIGURE 16 GLOBAL STERILITY TESTING MAJOR PLAYERS MARKET SHARE ANALYSIS, 2020 (%) 82

    FIGURE 17 GLOBAL STERILITY TESTING MARKET, COMPETITIVE LANDSCAPE, 2020 (%) 83

    Market Players have adopted the strategy of acquisitions, product launches, and partnerships for the development of the market


    Merck KGaA is the market leader in the global sterility testing market with a market share of 18.7% in 2016. The company has a well-developed market, strong product portfolio, and effective distribution network around the globe. In the last three years, Merck KGaA has adopted the organic strategy of product launches and acquisitions to cement their position in the global sterility testing market. Moreover, the company has also increased investments in various R&D activities. This enabled them to launch innovative products in the market, thereby, expanding their market reach.


    Charles River Laboratories Inc. assumed the second position in the global sterility testing market with a share of 12.4% in 2016. The company showed positive growth regarding revenue from 2015 to 2016 owing to strong sales in high potential emerging markets. Further, to sustain its place in the sterility testing market, the company follows strategic business strategies such as partnerships, collaborations, and acquisitions to expand their product portfolio and geographical reach. For instance, in July 2015, the company acquired Celsis International Ltd, which helped it in quality control testing of biopharmaceutical and consumer products industries.


    BioMérieux SA was third in the global sterility testing market with a share of 9.3% in 2016. The company adopted the strategy of product launches to expand its market share and keep the sterility testing market updated. In addition, the company has a huge product portfolio and good brand identity.


    Other prominent players in the market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company (BD), SGS SA, and Baxter BioPharma Solutions. Other players accounted for a share of 48.2% in the market in 2016. Majority of the companies have adopted the strategy of acquisitions and product launches for market development. For instance, in September 2016, the company announced the acquisition of the laboratory products and services segment of Alfa Aesar, a company based in the U.K., forUSD 392 million. This acquisition would help in expanding the company’s existing portfolio of chemicals, solvents, and reagents.